These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31602230)

  • 1. Knockdown of lncRNA CCEPR suppresses colorectal cancer progression.
    Duan Y; Fang Z; Shi Z; Zhang L
    Exp Ther Med; 2019 Nov; 18(5):3534-3542. PubMed ID: 31602230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of cervical carcinoma expressed PCNA regulatory long non-coding RNA promotes esophageal squamous cell carcinoma progression.
    Wang X; Zhou L; Zhang H; Ou H; Long W; Liu X
    Oncol Lett; 2020 Nov; 20(5):142. PubMed ID: 32934710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
    Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
    Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
    Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
    Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma.
    Teng J; Guo X; Wang H
    J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA.
    Sharma S; Munger K
    Virology; 2018 May; 518():8-13. PubMed ID: 29427865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer.
    Zhang R; Li JB; Yan XF; Jin K; Li WY; Xu J; Zhao J; Bai JH; Chen YZ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6801-6808. PubMed ID: 30402843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
    Zhao Q; Xu L; Sun X; Zhang K; Shen H; Tian Y; Sun F; Li Y
    Tumour Biol; 2017 Jun; 39(6):1010428317707881. PubMed ID: 28653875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
    Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
    Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PRNCR1 has an oncogenic role in breast cancer.
    Guo Q; Lv S; Wang B; Li Y; Cha N; Zhao R; Bao W; Jia B
    Exp Ther Med; 2019 Dec; 18(6):4547-4554. PubMed ID: 31798697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
    Fu X; Tian Y; Kuang W; Wen S; Guo W
    Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
    Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT
    Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.